

Ep. 1799 - There’s No Such Thing As Free Medicine
Aug 30, 2023
The discussion dives deep into the implications of Biden's Medicare drug pricing policy, weighing affordability against innovation. There’s a critical look at how proposed price cuts could impact pharmaceutical development. The episode tackles the politically charged atmosphere surrounding labor unions and their historical influence. A controversial debate unfolds over political expressions in schools, particularly relating to the Gadsden flag. As Hurricane Idalia looms, the conversation shifts to its political ramifications and the evolving landscape of late-night television.
AI Snips
Chapters
Books
Transcript
Episode notes
Unintended Consequences of Price Controls
- Lower drug prices may sound good, but medical innovation will likely suffer.
- Government price controls discourage investment in new drug development.
High Drug Development Costs
- Drug development costs are incredibly high, often reaching billions per drug.
- Profit margins are essential for companies to recoup these costs and fund further research.
Alternative Solution: Fair Pricing from Other Countries
- Instead of price controls, make other countries pay their fair share for American medications.
- This approach could support innovation without stifling drug development.